Dynamic cytokines signature predicts survival outcome from severe Immune-related hepatitis with PD-1/PD-L1 blockade in lung cancer.
Zeng L, Zhou Y, Xu Q, Huang Z, Song L, Wang Z, Deng L, Wu Y, Liang Y, Liu Z, Gao X, Yi X, He Q, Xia X, Yang H, Zhang X, Yan H, Qin H, Lin S, Yang N, Zhang Y.
Zeng L, et al.
Lung Cancer. 2023 Oct;184:107350. doi: 10.1016/j.lungcan.2023.107350. Epub 2023 Aug 28.
Lung Cancer. 2023.
PMID: 37659241